Table. Efficacy of sacubitril/valsartan compared to enalapril in chronic heart failure .
| Outcome | Sacubitril/valsartan 97/103 mg twice daily | Enalapril 10 mg twice daily |
|---|---|---|
| Composite primary outcome: death from cardiovascular causes or hospitalisation from worsening heart failure |
21.5% (914/4187) | 26.5% (1117/4212) |
| Death from cardiovascular causes | 13.3% (558/4187) | 16.5% (693/4212) |
| Hospitalisation from worsening heart failure | 12.8% (537/4187) | 15.6% (658/4212) |
Source: Reference 2